Home › New Hepatitis C med approved
 

Keywords :   


New Hepatitis C med approved

2014-10-11 07:16:24| Biotech - Topix.net

Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration has approved Harvoni , the first once-daily single tablet regimen for the treatment of chronic hepatitis C genotype 1 infection in adults. Harvoni combines the NS5A inhibitor ledipasvir with the nucleotide analog polymerase inhibitor sofosbuvir, approved under the tradename Sovaldi in December 2013.

Tags: med approved hepatitis

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
20.05Canada invests over $9.6M to prevent, prepare for African swine fever
20.05Dabbagh Named General Manager of Waldencast Ventures Glaze Brand
20.05Several pork priorities secured in House Farm Bill
20.05BT scraps digital landline switch deadline
20.05Essie Introduces Nail Art Studio
20.05Ilia Beauty Introduces Vegan Lip Sketch Hydrating Crayon
20.05Summer interest rate cut possible, says Bank deputy
20.05Eastern North Pacific Tropical Weather Outlook
More »